The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination
Author:
Affiliation:
1. Institute of Neuroanatomy, Faculty of Medicine; RWTH Aachen University; Aachen Germany
2. Pathology Department; VU University Medical Centre; Amsterdam The Netherlands
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12938/fullpdf
Reference71 articles.
1. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice;Acs;Glia,2009
2. Fingolimod is a potential novel therapy for multiple sclerosis;Aktas;Nat Rev Neurol,2010
3. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2013a
4. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes;Alexander;Br J Pharmacol,2013b
5. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis;Al-Izki;Mult Scler,2011
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting the PAC1 receptor mitigates degradation of myelin and synaptic markers and diminishes locomotor deficits in the cuprizone demyelination model;Journal of Neurochemistry;2024-08-08
2. The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice;Biomedicines;2024-03-06
3. The sphingosine 1‐phosphate analogue, FTY720, modulates the lipidomic signature of the mouse hippocampus;Journal of Neurochemistry;2024-02-09
4. An overall view of the most common experimental models for multiple sclerosis;Neurobiology of Disease;2023-08
5. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3